Literature DB >> 8521349

Comparison of protection of experimentally challenged cattle vaccinated once or twice with a Pasteurella haemolytica bacterial extract vaccine.

J A Conlon1, G F Gallo, P E Shewen, C Adlam.   

Abstract

Three groups of calves (15-18 per group) were injected twice at a 3-week interval with 2 doses of phosphate buffered saline (PBS, CONTROL group), 2 doses of PRESPONSE, a Pasteurella haemolytica A1 bacterial extract vaccine (PRESPONSE-2 group) or 1 dose of PBS followed by a 2nd vaccination with 1 dose of PRESPONSE (PRESPONSE-1 group). Three weeks after the 2nd vaccination, the calves were challenged intratracheally with P. haemolytica A1. Calves were evaluated clinically for 3 days prior to challenge and for 5 days after challenge. Six days postchallenge, calves were either euthanized or sent to slaughter and the lungs were evaluated for percent pneumonic tissue. There was a significant effect of single or double application of vaccine on clinical scores (P = 0.0409). Percent pneumonic tissue at necropsy was significantly affected by vaccine group (P = 0.014). Calves in the CONTROL group had significantly higher percent pneumonic tissue after arcsine transformation (45.30%) than calves in any group receiving PRESPONSE, regardless of vaccination frequency (25.18% and 25.78%, for calves receiving 2 doses or 1 dose of PRESPONSE, respectively). Both serum toxin neutralizing and direct agglutinating titers were negatively correlated with percent pneumonic tissue. Most importantly, 1 dose of PRESPONSE was as efficient as 2 doses at eliciting a protective immune response. It is concluded that the presence of P. haemolytica as a natural commensal in the upper respiratory tract of the calf can effectively prime the animal, and allow the animal to respond in an anamnestic nature to only 1 dose of this vaccine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521349      PMCID: PMC1263762     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  18 in total

1.  Pasteurella haemolytica serotype 1 colonization of the nasal passages of virus-infected calves.

Authors:  G H Frank; R E Briggs; K G Gillette
Journal:  Am J Vet Res       Date:  1987-12       Impact factor: 1.156

2.  Automated colorimetric assay for the detection of Pasteurella haemolytica leucotoxin.

Authors:  C N Greer; P E Shewen
Journal:  Vet Microbiol       Date:  1986-06       Impact factor: 3.293

3.  Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria.

Authors:  P E Shewen; B N Wilkie
Journal:  Am J Vet Res       Date:  1985-05       Impact factor: 1.156

4.  Prevalence of Pasteurella haemolytica in transported calves.

Authors:  G H Frank; P C Smith
Journal:  Am J Vet Res       Date:  1983-06       Impact factor: 1.156

5.  Aerosol vaccination of calves with pasteurella haemolytica against experimental respiratory disease.

Authors:  K W Jericho; E V Langford
Journal:  Can J Comp Med       Date:  1982-07

6.  Clinical and serological evaluation of a Pasteurella haemolytica A1 capsular polysaccharide vaccine.

Authors:  J A Conlon; P E Shewen
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

7.  Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1.

Authors:  J A Conlon; P E Shewen; R Y Lo
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

Review 8.  Molecular aspects of virulence of Pasteurella haemolytica.

Authors:  A W Confer; R J Panciera; K D Clinkenbeard; D A Mosier
Journal:  Can J Vet Res       Date:  1990-04       Impact factor: 1.310

9.  Serum neutralization of cytotoxin from Pasteurella haemolytica, serotype 1 and resistance to experimental bovine pneumonic pasteurellosis.

Authors:  M J Gentry; A W Confer; R J Panciera
Journal:  Vet Immunol Immunopathol       Date:  1985-07       Impact factor: 2.046

10.  Antibody titers to Pasteurella haemolytica A1 in Ontario beef cattle.

Authors:  P E Shewen; B N Wilkie
Journal:  Can J Comp Med       Date:  1982-10
View more
  5 in total

1.  Bovine respiratory disease: commercial vaccines currently available in Canada.

Authors:  S L Bowland; P E Shewen
Journal:  Can Vet J       Date:  2000-01       Impact factor: 1.008

2.  Comparison of a multivalent viral vaccine program versus a univalent viral vaccine program on animal health, feedlot performance, and carcass characteristics of feedlot calves.

Authors:  Oliver C Schunicht; Calvin W Booker; G Kee Jim; P Timothy Guichon; Brian K Wildman; Bruce W Hill
Journal:  Can Vet J       Date:  2003-01       Impact factor: 1.008

3.  Stimulation of the bronchus-associated lymphoid tissue of goats and its effect on in vitro colonization by Pasteurella haemolytica.

Authors:  A W Effendy; M Zamri-Saad; M A Maswati; M S Ismail; S M Jamil
Journal:  Vet Res Commun       Date:  1998-04       Impact factor: 2.459

4.  A comparison of 2 vaccination programs in feedlot calves at ultra-high risk of developing undifferentiated fever/bovine respiratory disease.

Authors:  Brian K Wildman; Tye Perrett; Sameeh M Abutarbush; P Timothy Guichon; Tom J Pittman; Calvin W Booker; Oliver C Schunicht; R Kent Fenton; G Kee Jim
Journal:  Can Vet J       Date:  2008-05       Impact factor: 1.008

5.  Seroepidemiology of undifferentiated fever in feedlot calves in western Canada.

Authors:  C W Booker; P T Guichon; G K Jim; O C Schunicht; R J Harland; P S Morley
Journal:  Can Vet J       Date:  1999-01       Impact factor: 1.008

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.